Teleflex Acquires Palette Life Sciences
October 10, 2023
Teleflex Incorporated completed its acquisition of Palette Life Sciences AB for $600 million in upfront cash plus up to $50 million in potential milestone payments. The deal adds Palette’s NASHA-based products — including the Barrigel rectal spacer, Deflux and Solesta — to Teleflex’s interventional urology portfolio; Palette’s standalone net revenue was expected to be about $56 million for 2023.
- Buyers
- Teleflex Incorporated
- Targets
- Palette Life Sciences AB
- Industry
- Medical Devices
- Location
- Sweden
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Tactile Medical Acquires LymphaTech
February 19, 2026
Medical Devices
Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech, Inc. for an upfront cash payment of $6.8 million plus potential milestone-based consideration to expand its lymphedema solutions into digital and connected care. LymphaTech co-founders joined Tactile to support commercial adoption and R&D as Tactile integrates the company’s 3D measurement and monitoring platform into its portfolio.
-
Coloplast to Acquire Atos Medical from PAI Partners for c. €2.2 billion
November 8, 2021
Medical Devices
Coloplast has agreed to acquire Atos Medical from private equity firm PAI Partners for an enterprise value of approximately €2.2 billion. Atos Medical, headquartered in Malmö, Sweden, is a global leader in laryngectomy and tracheostomy products with ~1,150 employees and a direct presence in 30 countries; the deal is subject to customary regulatory approvals and was anticipated to close in Q1 2022.
-
Fingerpaint Group Acquires PharmaHEALTHLabs
March 21, 2023
Healthcare Services
Fingerpaint Group has acquired PharmaHEALTHLabs, a specialized healthcare communications agency focused on oncology and biologics, and will rebrand it as Fingerpaint Medical Communications. The acquisition deepens Fingerpaint's medical and scientific communications capabilities as part of its Specialty Services offering; financial terms were not disclosed.
-
Biogen Acquires Alcyone Therapeutics
September 19, 2025
Medical Devices
Biogen has acquired Alcyone Therapeutics to obtain the ThecaFlex DRx intrathecal drug‑delivery system, integrating Alcyone employees into Biogen’s product delivery solutions team. Alcyone will receive $85 million upfront plus contingent milestone payments; Biogen will handle development, commercialization and manufacturing of ThecaFlex DRx while Alcyone’s remaining therapeutic assets are being divested into Neela Therapeutics.
-
Avantor Acquires Masterflex Bioprocessing Business from Antylia Scientific
September 7, 2021
Medical Devices
Avantor, Inc. agreed to acquire the Masterflex bioprocessing business and related assets from Antylia Scientific for $2.9 billion in an all-cash transaction (net purchase price approximately $2.7 billion after tax structure). Headquartered in Vernon Hills, Illinois, Masterflex is a manufacturer of peristaltic pumps and single-use fluid transfer technologies with estimated 2022 revenues of ~$300 million; the deal bolsters Avantor's single-use and bioproduction capabilities and is expected to be accretive to adjusted EPS in year one.
-
Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical
August 1, 2023
Medical Devices
Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.